You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 3, January 17, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CASE REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vesicular Eruption

A Local Complication of Concentrated Acyclovir Infusions

Robert K. Sylvester, PharmD; William B. Ogden, MD; Cheryl A. Draxler, PharmD; F. Bruce Lewis, MD

JAMA. 1986;255(3):385-386.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ANTIVIRAL agent acyclovir is effective in preventing progression of herpes zoster in immunocompromised patients.1-3 The following case report describes an immunocompromised patient who developed vesicles at three different intravenous (IV) acyclovir sites. A review of the literature and the package insert provided by Burroughs Wellcome Co failed to document previous similar occurrences.4

Report of a Case

A 60-year-old man came to the emergency department with a three-day history of left-sided facial pain associated with an erythematous vesicular eruption involving the maxillary division of the trigeminal nerve. No ocular involvement was noted. His medical history included chronic lymphocytic leukemia treated with splenectomy and chlorambucil and prednisone. A diagnosis of herpes zoster was made and, because of the proximity of the lesion to the eye and his underlying lymphoproliferative disease, he was admitted to the hospital for IV acyclovir sodium.

On the first day of therapy he received . . . [Full Text PDF of this Article]


Author Affiliations

From United Hospitals Inc, St Paul (Drs Sylvester, Ogden, and Lewis), and the University of Minnesota College of Pharmacy, Minneapolis (Dr Draxler).


Footnotes

Reprint requests to United Hospitals Inc, 333 N Smith Ave, St Paul, MN 55102 (Dr Sylvester).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.